Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report

Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report

Ziyu Jiang,1,2,* Xiaoli Chen,2,3,* Zhaoshen Sun,2,4 Xiaowei Shen,2,3 Yaju Huang,2,3 Jingbing Liu1,2 1Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People’s Republic of China...

Full description

Bibliographic Details
Main Authors: Jiang Z, Chen X, Sun Z, Shen X, Huang Y, Liu J
Format: Article
Language:English
Published: Dove Medical Press 2023-11-01
Series:Journal of Inflammation Research
Subjects:
sintilimab
checkpoint inhibitor
monoclonal antibody
nsclc
adverse effects.
Online Access:https://www.dovepress.com/toxic-epidermal-necrolysis-and-stevens---johnson-syndrome-following-si-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/toxic-epidermal-necrolysis-and-stevens---johnson-syndrome-following-si-peer-reviewed-fulltext-article-JIR

Similar Items